KKR Group Holdings Corp., 10% Owner at BridgeBio Pharma, Inc. (BBIO), sold 6,000,000 shares at $32.96 ($197.8M) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Open-market sale of $197.8M BBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRGY | SELL | 2024-04-03 | $64.4M | — | Filing → |
| CRGY | SELL | 2023-11-17 | $32.7M | — | Filing → |
| APP | SELL | 2023-08-23 | $552.8M | — | Filing → |